AI
HAE icon

Atria Investments’s Haemonetics HAE Stock Holding History

Atria Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,770
Closed -$269K – 2193
2026
Q1 		$269K Buy
+4,770
New +$311K ﹤0.01% 1820
2025
Q1 		– Sell
-3,330
Closed -$260K – 1947
2024
Q4 		$260K Buy
3,330
+109
+3% +$8.76K ﹤0.01% 1664
2024
Q3 		$259K Sell
3,221
-991
-24% -$80.1K ﹤0.01% 1685
2024
Q2 		$348K Buy
+4,212
New +$371K ﹤0.01% 1502

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atria Investments's HAE Position: Q2 2026 in Review

Atria Investments sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 4,770 shares — an estimated $269K sold.

Atria Investments first reported a position in HAE in Q2 2024 and held it in 4 quarters. The position peaked at $348K in Q2 2024. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Atria Investments reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Atria Investments sold 4,770 Haemonetics shares in Q2 2026, an estimated $269K.
  • Atria Investments first reported a position in Haemonetics in Q2 2024 and held it in 4 quarters.
  • Atria Investments's Haemonetics position peaked at $348K in Q2 2024.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.